original ) (raw )Effectiveness of two quadruple, tetracycline‐or clarithromycin‐containing, second‐line, Helicobacter pylori eradication therapies
Konstantinos Triantafyllou
View PDFchevron_right
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments
Antonietta Gravina , P. Solís-muñoz
Alimentary Pharmacology & Therapeutics, 2015
View PDFchevron_right
Efficacy of triple therapy with a proton pump inhibitor, levofloxacin, and amoxicillin as first-line treatment to eradicate Helicobacter pylori
manuel Pabon
Revista Española de Enfermedades Digestivas, 2009
View PDFchevron_right
Reevaluation of the Efficacy of First Line Regimen for Helicobacter pylori
Umar Kamal
Clinical and Experimental Gastroenterology, 2020
View PDFchevron_right
Seven-day PPI-triple therapy with levofloxacin is very effective for Helicobacter pylori eradication
Wink De Boer
The Netherlands Journal of Medicine
View PDFchevron_right
Efficacy of Clarithromycin Containing Bismuth-Based Regimen as a Second-Line Therapy in Helicobacter Pylori Eradication
Marjan Mokhtare
Middle East journal of digestive diseases, 2015
View PDFchevron_right
Neither 10- nor 14-Day Sequential Treatment is better than Standard Triple Therapy for Helicobacter Pylori Eradication
Doris Toro
2016
View PDFchevron_right
Efficacy and tolerability of a third-line, levofloxacin-based, 10-day sequential therapy in curing resistant Helicobacter pylori infection
Antonio Tursi
Journal of gastrointestinal and liver diseases : JGLD, 2012
View PDFchevron_right
A randomized controlled comparison of three quadruple therapy regimens in a population with low Helicobacter pylori eradication rates
Mohammed Fazel
Journal of Gastroenterology and Hepatology, 2001
View PDFchevron_right
A Randomized Controlled Trial: Efficacy and Safety of Azithromycin, Ofloxacin, Bismuth, and Omeprazole Compared With Amoxicillin, Clarithromycin, Bismuth, and Omeprazole as Second-Line Therapy in Patients With Helicobacter pylori Infection
Mohammad Minakari
Helicobacter, 2010
View PDFchevron_right
Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough
Xavier Calvet
Alimentary Pharmacology & Therapeutics, 2011
View PDFchevron_right
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial
Marcello Candelli
Alimentary Pharmacology and Therapeutics, 2003
View PDFchevron_right
First-line eradication rates comparing two shortened non-bismuth quadruple regimens against Helicobacter pylori: an open-label, randomized, multicentre clinical trial
Miguel Carrascosa
The Journal of antimicrobial chemotherapy, 2015
View PDFchevron_right
Twice a day quadruple therapy for the first-line treatment of Helicobacter pylori in an area with a high prevalence of background antibiotic resistance
Oykü Tayfur , Serkan Torun
Acta gastro-enterologica Belgica, 2013
View PDFchevron_right
Quadruple of Bismuth, Pantoprazole, Amoxicillin and Metronidazole for the First-Line Helicobacter Pylori Eradication Therapy
kadir yalçın
Lokman Hekim Health Sciences, 2021
View PDFchevron_right
Triple Therapy with High-Dose Proton-Pump Inhibitor, Amoxicillin, and Doxycycline Is Useless for Helicobacter pylori Eradication: A Proof-of-Concept Study
Maria Donato
Helicobacter, 2014
View PDFchevron_right
INCREASING RATES OF TREATMENT FAILURES WITH THE STANDARD TRIPLE THERAPY FOR HELICOBACTER PYLORI: A UNIQUE AND ALTERNATIVE TREATMENT OPTION IS URGENT
IJMRPS Journal
View PDFchevron_right
A Comparative Study of Sequential Therapy and Standard Triple Therapy for Helicobacter pylori Infection: A Randomized Multicenter Trial
Minhu Chen
The American Journal of Gastroenterology, 2014
View PDFchevron_right
Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication
Keng-liang Wu , Chien-chun Kuo
BioMed Research International, 2015
View PDFchevron_right
Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients
Olga Nyssen
Clinical Gastroenterology and Hepatology, 2019
View PDFchevron_right
Comparison of Two Commonly Used Sequential Therapy Regimens for Eradication of Helicobacter Pylori Infection
feroz wani
International Journal of Advanced Research
View PDFchevron_right
2-Week Triple Therapy for Helicobacter pylori Infection is Better Than 1-Week in Clinical Practice: a Large Prospective Single-Center Randomized Study
Federico Iacopini
Helicobacter, 2006
View PDFchevron_right
Sequential therapy versus standard triple therapy in Helicobacter pylori eradication in a high clarithromycin resistance setting
Emel Ahishali
International journal of clinical and experimental medicine, 2014
View PDFchevron_right
Inefficacy of triple therapy and comparison of two different bismuth-containing quadruple regimens as a firstline treatment option for helicobacter pylori
murat kekilli
Saudi Journal of Gastroenterology
View PDFchevron_right
Triple Drug Therapy with Proton Pump Inhibitor a Better Option for Helicobacter Pylori Eradication
Yeshwant Lamture
Medico-Legal Update, 2020
View PDFchevron_right
Efficacy and tolerability of fourteen-day sequential quadruple regimen: pantoprazole, bismuth, amoxicillin, metronidazole and or furazolidone as first-line therapy for eradication of Helicobacter pylori: a randomized, double-blind clinical trial
Fariborz Mansour-ghanaei
EXCLI Journal, 2019
View PDFchevron_right
Levofloxacin-Based Triple Therapy in First-Line Treatment for Helicobacter pylori Eradication
Marcello Candelli
The American Journal of Gastroenterology, 2006
View PDFchevron_right
Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study
Mario Rassu
Digestive and Liver Disease, 2000
View PDFchevron_right
Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study
Servet Güreşçi
Clinical Gastroenterology and Hepatology, 2013
View PDFchevron_right
Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line
Lucia Fini
World Journal of Gastroenterology, 2012
View PDFchevron_right
Clinical Evaluation of a Ten-Day Regimen with Esomeprazole, Metronidazole, Amoxicillin, and Clarithromycin for the Eradication of Helicobacter pylori in a High Clarithromycin Resistance Area
Dionyssios Sgouras
Helicobacter, 2013
View PDFchevron_right
First- and second-line Helicobacter pylori eradication with modified sequential therapy and modified levofloxacin-amoxicillin-based triple therapy
Cesare Efrati , Lorenzo Ridola , Domenico Alvaro
Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology, 2014
View PDFchevron_right
Levofloxacin versus clarithromycin in a 10 day triple therapy regimen for first-line Helicobacter pylori eradication: a single-blind randomized clinical trial
Miguel Carrascosa
Journal of Antimicrobial Chemotherapy, 2012
View PDFchevron_right